A patient initiated therapeutic plasma exchange (tpe), using a prismaflex tpe 2000 set and a prismaflex control unit.Two days later, approximately 30 minutes after starting the fourth tpe treatment session, with the fifth plasma bag infusion, the patient reportedly presented with an ¿anaphylactic shock level 3¿ with severe hypotension, facial edema, cutaneous rash, loss of consciousness, convulsions and cardiac arrest.The treatment was discontinued and the patient was provided both a bolus then with a continuous infusion of adrenaline for 12 hours.Resuscitation was successful and the patient is reported to have recovered without sequelae.No additional information is available.
|